Linda Elsegood

The LDN Book, Volume Two

The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More

• Broschiertes Buch

Produktbeschreibung

A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Chelsea Green Publishing Co
• Seitenzahl: 288
• Erscheinungstermin: 22. Oktober 2020
• Englisch
• Abmessung: 223mm x 151mm x 24mm
• Gewicht: 470g
• ISBN-13: 9781603589901
• ISBN-10: 1603589902
• Artikelnr.: 59270864

Autorenporträt

Linda Elsegood is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of The LDN Book. Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future. Through the Trust, she has connected thousands of patients, doctors, and pharmacists around the world with information, articles, and patient stories about LDN.